Elasmogen
Pre-clinicalElasmogen is a biopharmaceutical company developing next-generation soloMER™ biologics. We specialize in high-affinity, site-specific treatments for solid-tumor cancers and inflammatory diseases.
Founded
2005
Focus
Biologics
About
Elasmogen is a biopharmaceutical company developing next-generation soloMER™ biologics. We specialize in high-affinity, site-specific treatments for solid-tumor cancers and inflammatory diseases.
Funding History
3Total raised: $38.2M
Series B$21.5MBritish Business BankJul 15, 2022
Series A$12MAlumni VenturesOct 15, 2020
Seed$4.7MScottish EnterpriseMay 15, 2018
Company Info
TypePrivate
Founded2005
LocationAberdeen, United Kingdom
StagePre-clinical
Contact
SIMILAR COMPANIES
Abbexa
Pre-clinical · Cambridge
Accentus Medical
Pre-clinical · Oxford
AbOliGo
Pre-clinical · London
Bigespas
Pre-clinical · London
Actimed Therapeutics
Pre-clinical · London
Is this your company?
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile